Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile.

Lin TC, Jiang SS, Chou WC, Hou HA, Lin YM, Chang CL, Hsu CA, Tien HF, Lin LI.

J Mol Diagn. 2011 Sep;13(5):514-9. doi: 10.1016/j.jmoldx.2011.05.002. Epub 2011 Jun 30.

2.

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.

Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Zimmermann M, Peeters JK, Valk PJ, Balgobind BV, Sonneveld E, Kaspers GJ, de Bont ES, Trka J, Baruchel A, Creutzig U, Pieters R, Reinhardt D, Zwaan CM.

Haematologica. 2011 Mar;96(3):384-92. doi: 10.3324/haematol.2010.031336. Epub 2010 Dec 6.

3.

Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.

Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW.

Leuk Res. 2011 Feb;35(2):200-7. doi: 10.1016/j.leukres.2010.09.018. Epub 2010 Oct 20.

PMID:
20970189
4.

The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated.

Santana-Lemos BA, de Lima Lange AP, de Lira Benício MT, José TD, Lucena-Araújo AR, Krause A, Thomé CH, Rego EM.

Haematologica. 2011 Apr;96(4):617-20. doi: 10.3324/haematol.2010.028365. Epub 2010 Dec 6.

5.

Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia.

Chim CS, Wong AS, Kwong YL.

Br J Haematol. 2002 Dec;119(4):988-90.

PMID:
12472578
6.

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.

Lin TC, Hou HA, Chou WC, Ou DL, Yu SL, Tien HF, Lin LI.

Leukemia. 2011 Jan;25(1):32-40. doi: 10.1038/leu.2010.222. Epub 2010 Oct 7.

PMID:
20927134
7.

MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.

Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI.

Leuk Res. 2014 May;38(5):625-31. doi: 10.1016/j.leukres.2014.03.008. Epub 2014 Mar 19.

PMID:
24703161
8.

Methylation status of CEBPA gene promoter in chronic myeloid leukemia.

Annamaneni S, Kagita S, Gorre M, Digumarti RR, Satti V, Battini MR.

Hematology. 2014 Jan;19(1):42-4. doi: 10.1179/1607845413Y.0000000081. Epub 2013 Nov 25.

PMID:
23541085
9.

Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.

Figueroa ME, Wouters BJ, Skrabanek L, Glass J, Li Y, Erpelinck-Verschueren CA, Langerak AW, Löwenberg B, Fazzari M, Greally JM, Valk PJ, Melnick A, Delwel R.

Blood. 2009 Mar 19;113(12):2795-804. doi: 10.1182/blood-2008-08-172387. Epub 2009 Jan 23.

10.

CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.

Mannelli F, Ponziani V, Bencini S, Bonetti MI, Benelli M, Cutini I, Gianfaldoni G, Scappini B, Pancani F, Piccini M, Rondelli T, Caporale R, Gelli AM, Peruzzi B, Chiarini M, Borlenghi E, Spinelli O, Giupponi D, Zanghì P, Bassan R, Rambaldi A, Rossi G, Bosi A.

Haematologica. 2017 Mar;102(3):529-540. doi: 10.3324/haematol.2016.151910. Epub 2016 Nov 10.

11.

CEBPA methylation and mutation in myelodysplastic syndrome.

Wen XM, Hu JB, Yang J, Qian W, Yao DM, Deng ZQ, Zhang YY, Zhu XW, Guo H, Lin J, Qian J.

Med Oncol. 2015 Jul;32(7):192. doi: 10.1007/s12032-015-0605-z. Epub 2015 May 30.

PMID:
26025484
12.

[Analysis of CEBPA mutation in acute myeloid leukemia].

Zhang Y, Zhang SJ, Qiu HX, Qiao C, Sun HM, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):859-62. Chinese.

PMID:
20723288
13.

Detection of CEBPA double mutants in acute myeloid leukemia using a custom gene expression array.

van Vliet MH, Burgmer P, de Quartel L, Brand JP, de Best LC, Viëtor H, Löwenberg B, Valk PJ, van Beers EH.

Genet Test Mol Biomarkers. 2013 May;17(5):395-400. doi: 10.1089/gtmb.2012.0437. Epub 2013 Mar 13.

14.

Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.

Fasan A, Alpermann T, Haferlach C, Grossmann V, Roller A, Kohlmann A, Eder C, Kern W, Haferlach T, Schnittger S.

PLoS One. 2013;8(2):e54365. doi: 10.1371/journal.pone.0054365. Epub 2013 Feb 1.

15.

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA).

Preudhomme C, Sagot C, Boissel N, Cayuela JM, Tigaud I, de Botton S, Thomas X, Raffoux E, Lamandin C, Castaigne S, Fenaux P, Dombret H; ALFA Group.

Blood. 2002 Oct 15;100(8):2717-23.

16.

CpG site DNA methylation of the CCAAT/enhancer-binding protein, alpha promoter in chicken lines divergently selected for fatness.

Gao Y, Sun Y, Duan K, Shi H, Wang S, Li H, Wang N.

Anim Genet. 2015 Aug;46(4):410-7. doi: 10.1111/age.12326. Epub 2015 Jul 7.

PMID:
26156393
17.

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.

Fuster O, Barragán E, Bolufer P, Such E, Valencia A, Ibáñez M, Dolz S, de Juan I, Jiménez A, Gómez MT, Buño I, Martínez J, Cervera J, Montesinos P, Moscardó F, Sanz MÁ.

Ann Hematol. 2012 Jan;91(1):1-7. doi: 10.1007/s00277-011-1234-z. Epub 2011 May 3.

PMID:
21538063
18.

CEBPA gene mutational status: a complete screening using high-resolution melt curve analysis.

Rázga F, Dvoráková D, Jurcek T, Jezísková I, Krístková Z, Mayer J.

Mol Diagn Ther. 2009;13(3):195-200. doi: 10.2165/01250444-200913030-00004.

PMID:
19650672
19.

Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.

Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O.

Leuk Res. 2009 Mar;33(3):443-9. doi: 10.1016/j.leukres.2008.07.027. Epub 2008 Aug 30.

PMID:
18757096
20.

Supplemental Content

Support Center